Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 272-221-2 | CAS number: 68784-12-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://poisoncentres.echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
A theoretical assessment is performed taking into account physico-chemical
information and the results of toxicity studies on 2,5-Furandione,
dihydro-, mono-C15-20-alkenyl derivs. As a conclusion, the absorption via oral,
inhalation and dermal route is expected to be low. In addition,
the potential for bioaccumulation is also regarded as low.
Key value for chemical safety assessment
- Bioaccumulation potential:
- low bioaccumulation potential
- Absorption rate - oral (%):
- 10
- Absorption rate - dermal (%):
- 10
- Absorption rate - inhalation (%):
- 10
Additional information
Introduction
There are no studies available where the toxicokinetic behaviour of 2,5-Furandione, dihydro-, mono-C15-20-alkenyl derivs.was evaluated. Therefore a theoretical assessment is performed taking into account physico-chemical information and the results of toxicity studies on 2,5-Furandione, dihydro-, mono-C15-20-alkenyl derivs.
The compound of interest is a yellow viscous liquid, manufactured by a reaction of isomerized olefins with maleic anhydride. As the starting materials isomerized olefins are UVCB substances, their reaction product is also considered a UVCB. Based on the content of C15-C20 olefins in the starting material the main containing reaction products are assumed to be 2,5-Furandione, 3-(hexadecen-1-yl)dihydro- (CAS 32072-96-1), 2,5-Furandione, dihydro-3-(octadecen-1-yl)- (CAS 28777-98-2) and 2,5-Furandione, 3-(eicosen-1-yl)dihydro- (CAS 53520-67-5), respectively.
Table 1 Composition of 2,5-Furandione, dihydro-, mono-C15-20-alkenyl derivs. and main physic-chemical properties of components
| 2,5-Furandione, dihydro-, mono-C15-20-alkenyl derivs. | 2,5-Furandione, 3-(hexadecen-1-yl)dihydro- | 2,5-Furandione, dihydro-3-(octadecen-1-yl)- | 2,5-Furandione, 3-(eicosen-1-yl)dihydro- |
CAS No. | 68784-12-3 | 32072-96-1 | 28777-98-2 | 53520-67-5 |
Molecular weight | <500 | 322.49 | 350.55 | 378.60 |
Typical content % |
| ca. 50% | ca. 50% | ca. 5% |
Partition Coefficient (log Kow) | Log Kow = 8.46 – 10.42 Read-across | Log Kow = 8.46 (1) | Log Kow = 9.44 (1) | Log Kow = 10.42 (1) |
Water solubility | Unstable (0.017 mg/L) | 0.0048767 mg/L (2) | 0.00044701 mg/L (2) | 0.000040711 mg/L (2) |
(1) Estimated by KOWWIN v1.68
(2) Estimated by WATERNT v1.01
The substance 2,5-Furandione, dihydro-, mono-C15-20-alkenyl derivs. is a UVCB with an average molecular weight of < 500 g/mol. The substance is unstable in water as it dissociates with a half-life of 27 min at 70 °C in pure water and 80 min in water-THF (Lackinger 2010). Also, 97% hydrolysis was found after 14h at 37°C and pH 7.4 (AkzoNobel 2012). Due to the instability in water, any measurement of the partitioning coefficient is technically not feasible. The Log Pow was therefore derived from the calculated values of the containing components which were found to be in the range of 8.46 to 10.42 at 25°C.
The vapor pressure was found to be negligible(1E-06 Pa at 20°C).
Absorption
Absorption is a function of the potential for a substance to diffuse across biological membranes. In addition to molecular weight the most useful parameters providing information on this potential are the octanol/water partition coefficient (log Pow) value and the water solubility. These data of the substance 2,5-Furandione, dihydro-, mono-C15-20-alkenyl derivs. and of the listed individual components will be used to evaluate the toxicokinetic behaviour.
Oral
In general, a molecular weight < 500 is favourable for absorption via the biological membranes of the gastrointestinal tract (GI). For substances with log Pow >4 and low water solubility (< 1 mg/L) uptake via the GI tract is in general low, but some micellular solubilisation by bile salts in the gastro-intestinal tract may allow crossing of lipid biological membranes.
Based on the instability upon contact with water and the log Pow of 2,5-Furandione, dihydro-, mono-C15-20-alkenyl derivs. only some absorption of the substance is expected. The hydrolysis products may be slightly more water soluble, but are expected to have a high log Pow as well ( 6.74, as was calculated for a theoretical structure T16 H).
In the available repeated dose studies (OECD 422, OECD 408 and OECD 443) effects on liver and the gastrointestinal tract are reported that are related to test substance or its hydrolysis products, which confirms that some absorption must have occurred. In contrast, the acute and short-term oral studies in rats with 2,5-Furandione, dihydro-, mono-C15-20-alkenyl derivs. showed no substance related clinical signs and no mortality, leading to NOAEL values of 1000 mg/kg bw. The LD50 value was found to be >2000 mg/kg bw. These results are therefore considered indicative for limited absorption.
Dermal
As is the case for oral absorption, dermal absorption depends also on molecular size, water solubility and log Pow. With an average molecular size of < 500 g/mol and the instability upon contact with water, the absorption of the substance 2,5-Furandione, dihydro-, mono-C15-20-alkenyl derivs. is anticipated to be low. In addition, for the main components the rate of penetration may be limited by the rate of transfer between the stratum corneum and the epidermis due to the log Pow >5.0 (ECHA, 2017).
This is supported by the results of the acute dermal study with of the substance 2,5-Furandione, dihydro-, mono-C15-20-alkenyl derivs. show that neither systemic effects nor mortality was noted after application of 2000 mg/kg bw. Nevertheless, the substance was found to be a skin sensitizer, a property that can only become apparent when some absorption via the skin is anticipated. Therefore it is concluded that there are indications for limited absorption. This is in line with the outcome of permeability model calculations on the components, which suggest also a low absorption potential. Together the results indicate a limited dermal absorption of 2,5-Furandione, dihydro-, mono-C15-20-alkenyl derivs., and 10% dermal absorption will be used in risk assessment (default value).
Table 2 Calculated dermal absorption of components of 2,5-Furandione, dihydro-, mono-C15-20-alkenyl derivs.
|
| 2,5-Furandione, 3-(hexadecen-1-yl)dihydro- | 2,5-Furandione, dihydro-3-(octadecen-1-yl)- | 2,5-Furandione, 3-(eicosen-1-yl)dihydro- |
DERMWIN (US EPA) | Dermal Absorption (mg/cm²/h) | 1.07E-04 | 6.98E-06 | 9.35E-06 |
Absorption Potential | 10% | 10% | 10% | |
Ten Berge (2009) | Dermal Absorption (mg/cm²/h) | 6.48E-07 | 1.32E-08 | 5.12E-09 |
Absorption Potential | 10% | 10% | 10% | |
Danish (Q)SAR | Dermal Absorption (mg/cm²/event) | 0.00004 | 0.00002 | 0.00001 |
Absorption Potential | 10% | 10% | 10% |
Inhalation
Respiratory absorption is expected to be low due to the logPow and hydrolysis in water (set at 10% as default value). However, uptake by inhalation of the substance 2,5-Furandione, dihydro-, mono-C15-20-alkenyl derivs. is not expected, as the substance is a viscous liquid with a very low vapor pressure. Although the substance is used in solution and inhalation via aerosols might occur, the uses during the whole life cycle are not expected to release vapours or aerosols/mists containing respirable and/or inhalable droplets. Therefore exposure and concomitant uptake via inhalation can be excluded.
Metabolism
When any of the constituents would become bioavailable (bioavailability is expected to be very low in view of the low uptake), it is expected that the part of the constituents that is actually taken up, may be metabolized to some extent. It is considered that hydrolysis of 2,5-Furandione, dihydro-, mono-C15-20-alkenyl derivs. upon contact with body fluids is the earliest step in metabolism. The resulting alkenylated succinic acid is similar to (rare) naturally occurring fatty acids, alkylitaconates, which are known to be degraded in the liver (Adler et al., 1957). It is expected that the metabolic breakdown of alkenylated succinic acid occurs by binding of CoA and subsequent release of Acetyl-CoA, which is used in many metabolic steps (e.g. fatty acid synthesis) or degradation in the citric acid cycle. The other resulting molecule is an unsaturated fatty acid, for which the ß-oxidation is likely to be the major fate in mammals. Fatty acids are oxidized in mitochondria by a sequence of reactions in which the fatty alkyl chain is shortened two carbon atoms at a time.
However, in view of the complexity of the UVCB substance no further predictions of metabolism are included.
Excretion
The main route of excretion after oral administration is expected to be via the faeces without becoming systemically available. No bioaccumulation of the substance is expected.
Conclusion
The uptake of 2,5-Furandione, dihydro-, mono-C15-20-alkenyl derivs. via the oral, dermal and inhalation route is expected to be limited which is in line with the hazard assessment showing treatment related effects.
References
Adler, J. Shu-Fang Wang, AND Henry A. Lardy (1957): The metabolism of itaconic acid by liver mito¬chon-dria. . J Biol Chem. 1957 Dec;229(2):865-79. Available from:www.jbc.org/content/229/2/865.full.pdf
Danish (Q)SAR Database (2014), Danish EPA. Available at: http://qsar.food.dtu.dk/
ECHA Guidance on Information Requirements and Chemical Safety Assessment Chapter R.7c: Endpoint specific guidance Version 3.0, June 2017
Ten Berge, W. (2009): A simple dermal absorption model: derivation and application. Chemosphere. 2009 Jun;75(11):1440-5.
US EPA, 2012. Estimation Programs Interface Suite™ for Microsoft® Windows, v 4.11. United States Environmental Protection Agency, Washington, DC, USA.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)